Biomarkers of therapy responsiveness in asthma: pitfalls and promises.
about
Activation states of blood eosinophils in asthmaDawn of ocular gene therapy: implications for molecular diagnosis in retinal diseaseClinical application of exhaled nitric oxide measurements in a korean populationPersonalized health care beyond oncology: new indications for immunoassay-based companion diagnosticsInflammatory phenotypes underlying uncontrolled childhood asthma despite inhaled corticosteroid treatment: rationale and design of the PACMAN2 study.Platelet activation, P-selectin, and eosinophil β1-integrin activation in asthmaCurrent and future biomarkers in allergic asthma.Psychosocial factors and behavioral medicine interventions in asthma.Developments in the field of allergy in 2011 through the eyes of Clinical and Experimental Allergy.Exhaled breath analysis by electronic nose in airways disease. Established issues and key questions.Serum biomarkers in elderly asthma.Clinical utility of asthma biomarkers: from bench to bedsideAsthma phenotypes in children and stratified pharmacological treatment regimens.Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications.Inflammatory biomarkers for asthma endotyping and consequent personalized therapy.Exhaled NO is a poor marker of asthma control in children with a reported use of asthma medication: a pharmacy-based study.Exhaled nitric oxide measurement in patients affected by nasal polyposis.
P2860
Q26853383-0EA2D54A-66F7-4949-96E9-D9F6AD67E2BBQ27022731-CF081F3A-5381-4F9C-AFB7-7DFDD7C41E61Q28082277-48E959BF-BF54-46D5-A81F-60C8DBBEA5D2Q28084590-4A87E286-40F5-4AEB-9EB7-ADD3A22E4EFBQ34773924-17524FAE-0B60-4576-8368-0941B8415A66Q35813671-47CAF955-6A16-4A3C-A394-31ADDB8C9517Q35878914-0392C40C-D0B5-49FD-81D9-7B457CAC0E39Q38048331-F8BE642E-1727-4EDB-915F-137D0E40D1E0Q38062586-C5A2E333-72CA-48E7-8957-E18A762708C6Q38115808-D855C35D-06CF-4772-BFC6-4B8E03D6CB75Q38129447-1FB6B6BE-00F8-4653-A17E-6E51811091DBQ38134713-008AD132-2BE2-4842-8692-28830C236049Q39034456-27EB53E3-A051-4D97-AEC8-8485B8A4F473Q39063083-C4D5E68F-9A9A-43CE-B906-1FAB7AC4B5B3Q39202765-904A0600-C6F7-4719-81F2-BAD3F7659B30Q40036992-0A717494-37C6-4790-94B1-A671BC90C49CQ50953773-C137C8EE-1167-4F58-8932-C19DE94A7047
P2860
Biomarkers of therapy responsiveness in asthma: pitfalls and promises.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biomarkers of therapy responsiveness in asthma: pitfalls and promises.
@en
Biomarkers of therapy responsiveness in asthma: pitfalls and promises.
@nl
type
label
Biomarkers of therapy responsiveness in asthma: pitfalls and promises.
@en
Biomarkers of therapy responsiveness in asthma: pitfalls and promises.
@nl
prefLabel
Biomarkers of therapy responsiveness in asthma: pitfalls and promises.
@en
Biomarkers of therapy responsiveness in asthma: pitfalls and promises.
@nl
P2093
P2860
P1476
Biomarkers of therapy responsiveness in asthma: pitfalls and promises.
@en
P2093
A-H Maitland-van der Zee
C K van der Ent
E S Koster
J A M Raaijmakers
S J H Vijverberg
P2860
P304
P356
10.1111/J.1365-2222.2011.03694.X
P577
2011-05-01T00:00:00Z